# US 2024/0197646 A1 · Drug delivery system and methods of using the same

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0197646 A1
- Document ID: US20240197646A1
- Status: Published application
- Kind: A1
- Application number: 18/542,454
- Filed: 2023-12-15
- Published: 2024-06-20
- Earliest claimed: 2022-12-20
- Assignees: Axogen Corporation
- Applicants: Axogen Corporation
- Inventors: Kasra TAJDARAN; Justin DEUERLING; Angelo SCOPELIANOS; Xeve SILVER; Robert C. DILUCCIO; Nesreen ALSMADI
- Web page: https://patentgrep.com/patent/US20240197646A1

## CPC

- A61K 9/7007: {Drug-containing films, membranes or sheets (A61K9/0041, A61K9/0043, A61K9/006, A61K9/0063 take precedence)}
- A61K 9/0024: {Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue (compositions for intravenous administration, normal injectable solutions or dispersions for, e.g. subcutaneous administration A61K9/0019; brain implants A61K9/0085; (coated) prostheses, catheters or stents A61L)}
- A61K 31/436: the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
- A61K 47/32: Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers {, poly(meth)acrylates, or polyvinyl pyrrolidone}
- A61P 25/02: for peripheral neuropathies
- A61K 9/146: {with organic macromolecular compounds}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

A method of preparing an implantable biomaterial film includes inputting a combination of a polymer and a neuro-regenerative agent or an immunosuppressive agent into an extruder. The method includes melting the polymer within the extruder. The method also includes extruding the combined polymer and the neuro-regenerative agent or the immunosuppressive agent to form the implantable biomaterial film.

## Claims

### Claim 1

A method of preparing an implantable biomaterial film, comprising:
inputting a combination of a polymer and a neuro-regenerative agent or an immunosuppressive agent into an extruder;
melting the polymer within the extruder; and
extruding the combined polymer and the neuro-regenerative agent or the immunosuppressive agent to form the implantable biomaterial film.

### Claim 2 (depends on 1)

The method of claim 1, wherein the neuro-regenerative agent or the immunosuppressive agent includes FK506, rapamycin, or nimodipine.

### Claim 3 (depends on 1)

The method of claim 1, wherein the implantable biomaterial film has a thickness of about 10 μm to about 200 μm.

### Claim 4 (depends on 1)

The method of claim 1, wherein the implantable biomaterial film has a width of about 100 mm to about 6.4 mm.

### Claim 5 (depends on 1)

The method of claim 1, further comprising incorporating the implantable biomaterial film as part of an implant.

### Claim 6 (depends on 1)

The method of claim 1, further comprising incorporating the implantable biomaterial film into one of a nerve connector, a pre-rolled nerve wrap, a sheet-like nerve wrap, or a nerve graft.

### Claim 7 (depends on 5)

The method of claim 5, wherein the implant is a multi-layer implant.

### Claim 8 (depends on 5)

The method of claim 5, wherein the implantable biomaterial film is attached to an inner surface of the implant.

### Claim 9 (depends on 5)

The method of claim 5, wherein the implantable biomaterial film is attached to an outer surface of the implant.

### Claim 10 (depends on 5)

The method of claim 5, wherein a layer of the implant comprises a synthetic material in addition to the film.

### Claim 11 (depends on 1)

The method of claim 1, wherein the neuro-regenerative agent or the immunosuppressive agent comprises FK506, and the combination of the polymer and the FK506 input into the extruder includes about 1% to about 20% FK506, as measured by weight.

### Claim 12 (depends on 1)

The method of claim 1, wherein the neuro-regenerative agent or the immunosuppressive agent includes a plurality of neuro-regenerative agents, a plurality of immunosuppressive agents, or at least one neuro-regenerative agent and at least one immunosuppressive agent.

### Claim 13 (depends on 1)

The method of claim 1, wherein the neuro-regenerative agent or the immunosuppressive agent including at least one agent that is both neuro-regenerative and immunosuppressive.

### Claim 14 (depends on 1)

The method of claim 1, further comprising reducing a thickness of the extruded implantable biomaterial film by compressing and/or stretching the implantable biomaterial film using a film take off unit.

### Claim 15 (depends on 14)

The method of claim 14, wherein the film take off unit includes a pair of nip rollers that are spaced apart by a gap of about 10 μm to about 60 μm.

### Claim 16 (depends on 14)

The method of claim 14, further comprising operating the film take off unit at an approximately constant speed to facilitate formation of the implantable biomaterial film with an approximately constant thickness.

### Claim 17 (depends on 14)

The method of claim 14, further comprising operating the film take off unit at a speed that is about 2 times to about 5 times faster than a speed at which the polymer is extruded.

### Claim 18 (depends on 14)

The method of claim 14, wherein the film take off unit is operated at a speed such that a speed of the film immediately downstream of a roller of the film take off unit is about 0.3 meters per minute to about 6.1 meters per minute.

### Claim 19 (depends on 14)

The method of claim 14, further comprising collecting the implantable biomaterial film with the film take off unit.

### Claim 20 (depends on 14)

The method of claim 14, wherein a roller of the film take off unit is cooled with a liquid coolant.

### Claim 21 (depends on 1)

The method of claim 1, further comprising cutting the implantable biomaterial film into a plurality of sheets.

### Claim 22 (depends on 1)

The method of claim 1, wherein the polymer is a homopolymer, copolymer, and/or polymeric blend including one or more of the following monomers: glycolide, lactide, caprolactone, dioxanone, trimethylene carbonate, monomers of cellulose derivatives, and monomers that polymerize to form polyesters.

### Claim 23 (depends on 1)

The method of claim 1, wherein the polymer comprises polydioxanone.

### Claim 24 (depends on 1)

The method of claim 1, wherein the polymer comprises polydioxanone and a second polymer copolymerized with the polydioxanone.

### Claim 25 (depends on 1)

The method of claim 1, wherein the polymer comprises polydioxanone (PDS) and poly(trimethylene carbonate), poly(glycolide), poly(d,l-lactide), poly(l-lactide), or poly(caprolactone) as a copolymer with the PDS.

### Claim 26 (depends on 25)

The method of claim 25, wherein the copolymer is a random copolymer, the polymer comprising about 40% to about 90% PDS, by molecular weight.

### Claim 27 (depends on 25)

The method of claim 25, wherein the copolymer is a block copolymer, the polymer comprising about 45% to about 85% PDS, by molecular weight.

### Claim 28 (depends on 1)

The method of claim 1, wherein the polymer comprises polydioxanone (PDS) and at least one of poly(glycolide), poly(l-lactide), or poly(d,l-lactide) as a copolymer with the PDS.

### Claim 29 (depends on 23)

The method of claim 23, wherein the polymer is surface treated with polyethylene glycol.

### Claim 30 (depends on 1)

The method of claim 1, wherein the polymer contains a basic salt, the basic salt being about 0.5% to about 10% of the polymer, by molecular weight.

### Claim 31 (depends on 1)

The method of claim 1, further comprising cooling the implantable biomaterial film and collecting the implantable biomaterial film, the implantable biomaterial film including the polymer combined with FK506 as the neuro-regenerative or immunosuppressive agent.
